Webinar: Getting real with real-world evidence: A discussion on building successful programs

The BioPharma industry has invested heavily in RWE programs and early adopters have seen promise in areas such as label expansion, safety studies, and clinical trial design. However, most organizations still wrestle with challenges like:
– How do we integrate large volumes of real-world data, including unstructured and semi-structured, and make it available to the teams that need it the most? – How do we ensure reproducibility in RWE studies?

Read the source article at pharmalive.com
2022-01-03 22:22:56